Keratoconus Treatment in China 2026: cross-linking, rings, lenses
Corneal cross-linking in China runs $900–1,700 per eye, intracorneal ring segments $1,800–3,200 per eye, and a scleral-lens fitting with a first lens $600–1,200 per eye (standard ranges, researched July 2026) — against published US private-pay cross-linking of $2,500–4,000 and as much as $6,000 per eye. But keratoconus is the condition where the price is the least useful number on the page. Cross-linking stops the cornea getting worse; it does not give you your vision back, and it is only indicated when progression has actually been documented on serial scans. This page separates the stabilising half of the treatment from the seeing half, and says plainly where flying is the wrong decision.
Epi-off cross-linking $900–1,700 per eye · epi-on $1,000–1,800 · both eyes in one trip $1,700–3,000 · ring segments $1,800–3,200 per eye · rings with cross-linking $2,400–4,000 · RGP fitting $250–600 per eye · scleral fitting $600–1,200. Trip 7–10 days for cross-linking. Two things decide whether any of it applies to you, and neither is money: two tomography scans taken at different visits showing the cornea is changing, and enough corneal thickness to treat safely. If you are insured in a country where cross-linking is funded for documented progression, check that first — for many readers the honest answer is that the trip is unnecessary.
Cross-linking uses riboflavin and ultraviolet-A light to stiffen the collagen in the corneal stroma. Its purpose is structural: to arrest the progressive thinning and steepening that makes a keratoconic cornea worse over time. In published series it produces modest flattening of the steepest corneal reading — on the order of 1.0–2.3 dioptres of Kmax change at 12–36 months for conventional epithelium-off treatment — and corrected vision that is typically unchanged or slightly improved.
What it is not is a vision-correcting operation. It will not make you glasses-independent, it does not reverse the shape change that has already happened, and it is not a substitute for the lenses that give a keratoconic eye usable sight. Nor is it laser vision correction: keratoconus is a contraindication to conventional LASIK and SMILE, which is precisely why an unrecognised early cone found during a refractive-surgery screening is a finding worth taking seriously rather than shopping around.
If a clinic's page for "keratoconus treatment in China" leads with vision restoration and a price, and never mentions serial tomography or corneal thickness, it is selling a procedure rather than assessing a cornea.
The gate: documented progression, on two scans
In adults, cross-linking is indicated for keratoconus that is progressing — and "progressing" is a measurement, not an impression. It requires at least two corneal tomography or topography examinations taken at different visits, ideally on the same instrument so the maps are comparable. The thresholds used most widely in the literature:
| What is compared | Change that counts as progression | Why it is measured that way |
|---|---|---|
| Kmax (steepest corneal reading) | ≥ 1.00 D steepening | The most frequently used single criterion in published series |
| Spherical-equivalent refraction | ≥ 0.50 D change | Captures a cone changing your prescription even when maps look stable |
| Central corneal thickness | ≈ 10 µm thinning | Thinning often precedes visible steepening |
| A single scan showing keratoconus | Not progression | Establishes the diagnosis only — it says nothing about direction |
The practical consequence is the most useful thing on this page. If you have one scan, get the second at home before you book anything. Repeat imaging is inexpensive and widely available; a long flight that ends in "come back in six months so we can compare" is not. Bring the raw tomography — the printed maps or the exported files, not a summary letter — because a Chinese corneal specialist needs to compare like with like.
Keratoconus in children and adolescents behaves differently: it tends to be more severe at presentation and to progress faster, and follow-up intervals are correspondingly shorter. Expert consensus published in 2025 supported cross-linking at the time of diagnosis in paediatric patients without waiting for documented progression, alongside unanimous agreement that cross-linking should be performed wherever tomographic or topographic progression is shown at any age. So the "wait and document" rule that protects an adult from an unnecessary procedure can work against a teenager. If a young family member has just been diagnosed, the appropriate urgency is a prompt corneal-specialist assessment — the decision remains theirs to make. For the more common paediatric question, ordinary short-sightedness that is progressing, see our guide to myopia control for children in China, which covers the same tension between acting early and over-treating.
The other gate: is there enough cornea to treat?
Standard epithelium-off protocols are generally performed where stromal thickness after epithelial removal is at least about 400 µm, because the ultraviolet dose has to be kept safely away from the corneal endothelium — the single cell layer that keeps the cornea clear and does not regenerate. Thinner corneas may be handled with modified protocols at a surgeon's discretion, or may simply be past the point where cross-linking is the useful intervention.
Other reasons a corneal specialist may decline: significant central scarring (which is already limiting vision that stiffening will not recover), a history of herpetic keratitis, severe dry eye or ocular-surface disease, and poor healing risk. None of these are negotiable by paying more, and a provider who treats them as paperwork rather than contraindications is the wrong provider.
What is on the table, by stage — and when travel makes no sense
| Where you are | What is usually discussed | Worth travelling? |
|---|---|---|
| Suspect / very early, no documented change | Serial tomography every 6–12 months, stop eye rubbing, treat allergy | No — this is monitoring, done at home |
| Documented progression, adequate thickness | Cross-linking, then refraction and lens work once stable | Yes, if not funded where you live |
| Newly diagnosed child or teenager | Prompt specialist assessment; cross-linking often without waiting for documented change | Assess locally first — speed matters more than price |
| Stable cornea, poor vision in glasses | RGP, hybrid or scleral lens fitting; ring segments in selected corneas | Only with local follow-up arranged for remakes |
| Contact-lens intolerant, clear central cornea | Ring segments, sometimes combined with cross-linking | Yes — a reasonable single-trip combination |
| Dense central scarring or too thin/irregular for lenses | DALK or penetrating keratoplasty | A different decision entirely — see the graft page |
| Sudden pain, marked clouding, rapid vision loss (hydrops) | Urgent local ophthalmology, same week | No — never a planned trip |
What it costs (researched July 2026)
| Item | China (standard range) | US private-pay | Notes |
|---|---|---|---|
| Corneal tomography + staging work-up, both eyes | $150–350 | $300–800 | Scheimpflug or OCT-based maps, pachymetry, endothelial count where indicated |
| Epithelium-off cross-linking, per eye | $900–1,700 | $2,500–4,000 (to $6,000) | Conventional (Dresden) or accelerated protocol — the surgeon's choice, not a menu item |
| Transepithelial (epi-on) cross-linking, per eye | $1,000–1,800 | $2,500–4,500 | Less surface pain; weaker and more variable published effect. Generally not insured anywhere |
| Both eyes cross-linked in one trip | $1,700–3,000 | $5,000–8,000 | Same-session or staged days apart; adds 2–3 days to the visit |
| Intracorneal ring segments, per eye | $1,800–3,200 | From ~$2,000, commonly $3,000–5,000 | Femtosecond channel creation; segment type chosen from your topography |
| Ring segments + cross-linking, per eye | $2,400–4,000 | $5,000–8,000 | Often sequenced rather than combined — ask which, and why |
| Corneal RGP or hybrid fitting incl. first lens, per eye | $250–600 | $500–1,500 | Multiple fitting visits; budget for at least one remake |
| Scleral lens fitting incl. first lens, per eye | $600–1,200 | $1,500–3,500 | Published US per-lens averages sit near $1,000 before customisation |
| Follow-up tomography visit | $80–200 | $150–400 | Usually done at home — the comparison matters more than the location |
| DALK graft, per eye (if it comes to that) | $4,000–7,500 | $14,000–27,000 | See the corneal transplant guide |
Ranges are standard partner-hospital fee schedules researched July 2026 against published US private-pay references; Western-European private rates typically sit 20–35% below the US figures. Cross-linking is one of the smaller ticket items in eye surgery, which cuts both ways: the saving on a single procedure may not justify the airfare on its own, while a trip covering tomography, cross-linking of both eyes, and a scleral-lens fitting compares much better. For every other procedure, see the full China eye surgery price guide.
This is the section a facilitator has no commercial reason to write. In the United States, the FDA-approved epithelium-off procedure is covered by most major commercial insurers when progression has been documented on topography taken at separate visits; Medicare is a noted exception, and epithelium-on protocols are generally not covered. Coverage also exists under several national and private systems elsewhere. If you are insured and your progression is documented, the sensible first call is to your own plan, not to us.
Travelling earns its place in narrower circumstances: you are uninsured or facing a deductible larger than the whole procedure; cross-linking is not funded or not readily available where you live; you want both eyes and a lens fitting handled in one compressed window; or you need ring segments, which are funded far less consistently than cross-linking. Confirm any coverage question with your plan administrator or insurer before you commit — we are not able to advise on your policy, and nothing here is insurance advice. The general mechanics — what reimburses treatment abroad, what a US HSA or FSA can cover, and the itemised bill a foreign hospital has to issue for either — are set out on our insurance, HSA/FSA and records guide.
Published outcomes, and what "success" means here
Success in cross-linking means the cornea stopped changing — a lower bar to state and a harder one to feel. Comparative work reports stabilisation in the region of 90–96% of treated eyes for conventional and accelerated protocols respectively in one series, with no statistically significant difference between them, and a systematic review finding that conventional epithelium-off treatment showed the most consistent long-term keratometric stabilisation, with mean Kmax flattening of roughly 1.0–2.3 D at 12–36 months and durability extending to five years. Accelerated protocols achieved comparable short-term results — around 0.8–1.5 D of Kmax flattening at 6–12 months — but with greater variability in durability at longer follow-up. Transepithelial approaches spare the patient the painful epithelial defect and deliver a weaker, more variable effect.
Two honest caveats. First, these are population figures from study cohorts and do not predict your eye; a minority of eyes progress despite treatment and may be considered for re-treatment. Second, the choice of protocol is a clinical judgement made from your thickness, your age and your rate of change — if a provider offers you a protocol as a price tier, they have the decision the wrong way round.
The half that actually restores vision
Keratoconus degrades sight by making the corneal surface irregular, and no amount of stiffening fixes irregularity that already exists. Glasses correct sphere and regular astigmatism; they cannot correct a distorted surface. A rigid gas-permeable, hybrid or scleral lens can, by placing a smooth optical surface in front of the cornea with a tear layer between. For most people with established keratoconus this is where the usable vision comes from, and it deserves as much attention as the surgical decision.
- Corneal RGP — the long-established option; excellent optics, and comfort depends heavily on fit and on how steep the cone is.
- Hybrid lenses — rigid centre with a soft skirt, often a compromise when RGPs decentre or feel intolerable.
- Scleral lenses — vault the whole cornea and rest on the sclera; usually the most comfortable answer for advanced or irregular corneas, and the most technically demanding to fit.
- Ring segments — implanted in the corneal periphery to flatten and regularise a cone, frequently used to make an intolerant eye lens-tolerable again rather than to replace lenses.
Topography-guided surface ablation combined with cross-linking exists as a way to regularise selected stable corneas; it is a refractive-surface procedure with its own candidacy limits, and it is not a route back to routine laser vision correction, which keratoconus rules out.
Phakic lens implants (ICL) once a cornea is stable — the option this page owed you
There is a third route, narrower than the two above and routinely misdescribed by clinics on both sides of the world. A phakic implantable collamer lens — an ICL — is a soft lens placed inside the eye, behind the iris and in front of your natural lens. It removes no corneal tissue, which is the whole reason it is discussable in an eye where LASIK and SMILE are contraindicated. It is not laser vision correction and nothing in this section changes the rule that laser is ruled out in keratoconus.
What it does is correct the regular part of your prescription — the sphere and the regular cylinder — in an eye whose cone has already been stopped. What it cannot do is regularise a distorted surface. That distinction decides almost every case.
An ICL does nothing to stop keratoconus progressing. Cross-linking does that. Implanting a lens into an eye whose cone is still moving buys you a prescription that will be wrong within a year, and the published sequences all stabilise first:
- Cross-linking first, if there is documented progression — and in selected corneas ring segments before or alongside it, to regularise the cone.
- Then wait, and re-image. Published toric-ICL series in keratoconus implanted roughly six months after cross-linking; the wider refractive-surgery convention is a refraction stable within about 0.5 D for at least twelve months, and some published ICL criteria ask for two years. The point is that stability is demonstrated on repeat tomography, not asserted because a date has passed.
- Only then is the lens calculation done, on measurements taken after stabilisation.
Who qualifies — and these gates are checked, not asked about
| What is measured | What is generally looked for | Why it is the gate |
|---|---|---|
| Progression status | Stable, documented on repeat scans | Documented progression or advanced keratoconus is a reason not to implant, not a reason to hurry |
| Spectacle-corrected vision | Around 20/50 or better with glasses | The decisive one. If you only see well in a rigid lens, an ICL will not reproduce that — see below |
| Regularity of the astigmatism | No clinically significant irregular astigmatism | A toric lens corrects a regular axis; an irregular cone has no single axis to correct |
| Central cornea | Clear — no dense or post-hydrops scar | A scarred visual axis is a graft conversation, not a lens one |
| Endothelial cell density | Commonly ≥2,000 cells/mm² | The lens sits in a crowded eye for decades; approved labelling sets age-banded minimums in the 1,900–3,875 range |
| Anterior chamber depth | ≥2.8 mm, with ≥3.0 mm preferred | Space for the lens; shallower chambers carry more endothelial risk over time |
| Angle on gonioscopy | Grade 2 or wider | A narrow angle is an explicit contraindication in the approved labelling |
| Age | Typically 21–45 | Younger eyes are more likely to still be progressing; older eyes approach a lens-replacement decision instead |
The honest limit, stated before the price
Keratoconus degrades vision two ways: it makes you short-sighted and astigmatic, and it makes the corneal surface irregular. An ICL fixes the first and leaves the second untouched. The corneal higher-order aberrations stay exactly where they were, and they are what produce the ghosting, monocular double vision, halos and starbursts that people with cones describe. A scleral lens neutralises those aberrations by floating a smooth optical surface over the cornea in a tear reservoir; an implanted lens cannot, because it sits behind the problem rather than in front of it.
So the realistic comparison is not "ICL versus scleral lens, which sees better" — a well-fitted scleral often wins that on the eye chart. It is "can I have usable vision without a lens in my eye every day", for someone who has tried rigid lenses and cannot tolerate them, or whose life makes daily lens wear impractical. Framed that way it is a genuine option for a small number of people. Framed as an upgrade over sclerals it is a mis-sale.
Two further things a candid surgeon will raise. In keratoconus this is an off-label or specialist-judgement use in most jurisdictions — keratoconus is not a labelled indication for these lenses, though it is not an explicit labelled contraindication either, and the published evidence is a body of small series with follow-up measured in a few years rather than decades. And a toric lens has to stay on axis: rotation costs you correction, and it matters more here than in an ordinary myopic eye because there is less regular astigmatism to spare.
What it costs
An ICL is priced as refractive surgery rather than as corneal disease treatment, and it is not funded by insurers anywhere. Our standard dated range for EVO ICL, both eyes, is $3,800–4,800 in China against $8,000–10,000 US private-pay and €6,000–8,000 in Europe — roughly a 50% saving, and that figure sits on our main price table with the rest of the refractive procedures. A keratoconic eye adds the stabilising work in front of it, so the honest budget is the cross-linking and staging figures in the table above plus the lens, across two visits rather than one, with months in between. Anyone quoting you a single combined price for a same-trip "cross-link and implant" package has skipped the waiting period that makes the lens calculation valid.
Ranges are researched July 2026 and are indicative, not quotations. Whether an ICL is appropriate for your eyes is a decision for the operating surgeon after tomography, biometry and an endothelial count — it is not a purchase you can specify in advance, and a straight answer of "no, stay in a scleral lens" is a legitimate outcome of that examination.
Two things follow you home from this trip, and both need someone there:
- Surveillance. The only way to know whether cross-linking worked is repeat tomography over years, compared against the pre-treatment maps. Take your full imaging set, the treatment protocol used and the drop schedule with you, and have an ophthalmologist or optometrist at home who will hold the baseline and repeat the scans.
- Lens care. Fitting is iterative. Lenses need adjustment, periodic remakes and replacement after loss or damage, and a cornea that changes shape needs a refit. Assuming remakes can be managed from another continent is the most common way a good fitting turns into a drawer full of unwearable lenses.
If neither exists yet, arranging them is step one — before flights, and before any date is discussed.
The free things that matter more than the purchase
Two facts sit awkwardly beside a price page, and both are worth more to a keratoconic eye than any comparison of quotes.
- Stop rubbing your eyes. Eye rubbing is the most consistently reported modifiable risk factor in keratoconus, and in a multicentre Chinese hospital cohort 68.4% of patients had a history of it. Where rubbing is driven by allergy or dryness, treating the itch is part of treating the cone — worth raising at every visit.
- Age at diagnosis is young. In the same Chinese hospital data the mean age at diagnosis was around 21 years, an age at which the cornea has the most time left to change. That is the argument for taking a new diagnosis seriously and for keeping the monitoring appointments, rather than for rushing to buy a procedure.
Family members matter too: first-degree relatives of people with keratoconus carry a higher risk than the general population, and a baseline tomography for a sibling or child is a small, cheap thing to arrange locally.
The trip, and flying home
| Pathway | Time in China | Shape of the visit |
|---|---|---|
| Assessment / second opinion only | 2–4 days | Tomography, pachymetry, refraction, written opinion on staging and whether treatment is indicated |
| Cross-linking, one eye | 7–10 days | Work-up, treatment, bandage lens, healing reviews, clearance |
| Cross-linking, both eyes | 10–14 days | Same-session or staged; the second eye extends the uncomfortable window |
| Ring segments (± cross-linking) | 5–7 days | Femtosecond channels, segment placement, early review; refraction settles over weeks |
| Specialty lens fitting | 5–10 days | Diagnostic fitting, lens manufacture, collection and adjustment — plan for at least one iteration |
What recovery actually feels like: after epithelium-off treatment the surface is a deliberate abrasion. Expect 2–4 days of real discomfort — light sensitivity, watering, a gritty foreign-body sensation — under a bandage contact lens, then blurrier-than-usual vision for several weeks while the cornea settles, sometimes with a faint haze that fades over months. There is no gas bubble in the eye, so none of the pressure-related no-fly rules that apply after retinal or endothelial-graft surgery are relevant here; the constraint is simply that the surgeon should confirm a healed epithelium before you travel, usually around day 5–7. Our flying-after-eye-surgery guide sets out the windows by procedure.
Where this work is done in China
Cross-linking, ring segments and specialty lens fitting belong in dedicated corneal and contact-lens services — the academic eye centres with corneal subspecialists, current tomography and a lens-fitting clinic under the same roof, rather than a refractive-surgery chain whose main business is laser correction for normal eyes. China's keratoconus research literature comes out of those centres, including hospital-based cohorts from Henan Eye Hospital and multicentre work involving the Shandong and Qingdao eye hospitals, which is a reasonable proxy for where the clinical volume sits.
Our best eye hospitals guide profiles the major institutions and how to choose between them, the city comparison weighs access and flights, and the for-foreigners guide covers international departments, English records and payment. Our safety assessment addresses the standards question directly. If your cornea turns out to be past cross-linking, the corneal transplant guide covers what a DALK actually involves — including the aftercare commitment that makes it a much larger decision than this one.
Frequently asked questions
Can you have ICL surgery if you have keratoconus?
Sometimes — but only in a cornea that has been stabilised first, and only for a minority of eyes. A phakic implantable collamer lens removes no corneal tissue, so unlike LASIK and SMILE it is not automatically ruled out. The gates that matter are: keratoconus documented as stable rather than progressing, spectacle-corrected vision of roughly 20/50 or better, no clinically significant irregular astigmatism, a clear central cornea, endothelial cell density commonly at or above 2,000 cells/mm², an anterior chamber of at least 2.8 mm, and an open angle. Published series implanted toric ICLs around six months after cross-linking, and wider refractive practice asks for a refraction stable within about 0.5 D for at least a year, demonstrated on repeat tomography. Documented progression or advanced keratoconus is a reason not to implant. In keratoconus this remains an off-label or specialist-judgement use in most jurisdictions, and candidacy is decided by the operating surgeon after imaging, not in advance.
Will an ICL give me better vision than my scleral lens?
Usually not on the eye chart, and it is worth being clear about why. An ICL corrects the regular part of your prescription — sphere and regular cylinder — and leaves the corneal higher-order aberrations completely untouched. Those aberrations are what cause the ghosting, monocular double vision and halos of a cone. A scleral lens neutralises them by placing a smooth optical surface over the cornea with a tear layer between, which an implanted lens sitting behind the cornea cannot do. So a well-fitted scleral often gives the better measured acuity. The real question an ICL answers is different: whether you can have usable everyday vision without wearing a lens, which matters if you have tried rigid lenses and cannot tolerate them. Presented as an upgrade over a scleral lens it is a mis-sale; presented as freedom from daily lens wear for a suitable stable eye, it is a fair option.
How much does corneal cross-linking cost in China?
Standard partner-hospital ranges researched July 2026: epithelium-off cross-linking $900–1,700 per eye, transepithelial (epi-on) $1,000–1,800 per eye, and $1,700–3,000 for both eyes treated in one trip. Corneal tomography and the staging work-up run $150–350 for both eyes. Published US private-pay figures for cross-linking are commonly $2,500–4,000 per eye, with some centres up to $6,000. Final pricing follows examination and imaging, and candidacy is the operating surgeon's decision rather than a purchase choice.
Does cross-linking improve vision?
That is the most important misunderstanding to clear up. Cross-linking is a stabilising procedure: it stiffens corneal collagen to stop keratoconus getting worse. Published series show modest flattening of the steepest corneal reading — on the order of 1.0 to 2.3 dioptres of Kmax change at 12 to 36 months — and corrected vision that is usually unchanged or slightly better. It is not a vision-correcting operation. The part of the treatment that actually restores usable sight is optical: rigid gas-permeable, hybrid or scleral contact lenses, sometimes with intracorneal ring segments to make a cornea more lens-tolerable. Any provider presenting cross-linking as a way to get your vision back is describing something the procedure does not do.
What evidence of progression do I need before cross-linking?
For adults, cross-linking is indicated for keratoconus documented as progressing, and documentation means at least two corneal tomography or topography scans taken at different visits, ideally on the same instrument. The criteria used most often in the literature are a steepening of Kmax of at least 1.00 dioptre over a year or longer, a change in spherical-equivalent refraction of at least 0.50 dioptre, or thinning of central corneal thickness of about 10 micrometres. One scan showing keratoconus establishes the diagnosis but says nothing about whether it is changing. This matters practically: if you arrive with a single scan, the honest answer may be that you need serial measurements before anyone should treat you — so obtain them at home before booking. Children are treated differently; see the paediatric answer below.
Is the paediatric approach different?
Yes, and the difference is deliberate. Keratoconus in children and adolescents tends to be more severe and to progress faster, and expert consensus published in 2025 supported cross-linking at the time of diagnosis in paediatric patients without waiting for documented progression, alongside unanimous agreement that cross-linking should be performed where tomographic or topographic progression is shown at any age. Follow-up intervals are also shorter in children. The decision still belongs to the treating corneal specialist, and a young patient should be assessed by one promptly rather than watched casually.
Is my cornea too thin for cross-linking?
It can be. Standard epithelium-off protocols are generally performed on corneas of at least about 400 micrometres of stromal thickness after the epithelium is removed, because the ultraviolet dose has to be kept away from the corneal endothelium. Thinner corneas may be candidates for modified approaches at a surgeon's discretion, or may be past the point where cross-linking is the useful intervention — in which case the conversation moves to specialty lenses, ring segments in selected corneas, or eventually a deep anterior lamellar graft. Significant central scarring, previous herpetic infection and severe ocular-surface disease are also reasons a surgeon may decline. This is why the tomography, not the price list, decides what happens.
Should I travel for cross-linking at all?
Not always, and we would rather say so. In the United States the FDA-approved epithelium-off procedure is covered by most major commercial insurers when progression has been documented — Medicare is a noted exception, and epithelium-on protocols are generally not covered — so an insured patient with documented progression should check their own coverage before pricing a trip. Travelling makes more sense where you are uninsured or facing a high deductible, where cross-linking is not funded or not readily available where you live, where both eyes need treating in one compressed window, or where you want cross-linking, ring segments and a proper scleral-lens fitting arranged in a single visit. Confirm coverage with your plan administrator or insurer before you commit to travel; we cannot advise on your policy.
How long does the trip take and how soon can I fly?
For epithelium-off cross-linking allow 7–10 days in China: work-up and tomography, treatment, a bandage contact lens, and the review at which the surgeon confirms the surface has healed. The first 2–4 days are genuinely uncomfortable — light sensitivity, watering, a gritty eye — and vision is often blurrier for several weeks before it settles. There is no gas bubble in the eye, so there is no pressure-related flight restriction of the kind that applies after retinal or endothelial-graft surgery; the constraint is simply that the surgeon should see the healed epithelium before you fly, which is usually around day 5–7. Ring segment surgery typically needs 5–7 days, and a scleral-lens fitting needs to be planned around remakes.
What happens after cross-linking, and can that be done at home?
It must be. Cross-linking aims to stop progression, but the only way to know whether it worked is repeated corneal tomography over years, compared against your pre-treatment scans. That means an ophthalmologist or optometrist at home who can repeat the imaging, hold the baseline maps, manage your lens wear and re-refer if the cornea changes again. Before travelling, arrange that person and take away your full imaging set, the treatment protocol used, and the post-operative drop schedule. A small proportion of eyes continue to progress after treatment and may be considered for re-treatment, which is another reason surveillance is not optional.
Do rigid or scleral lenses work better than surgery for keratoconus?
They do a different job, and for most people they are the part that restores functional vision. A rigid gas-permeable, hybrid or scleral lens creates a smooth optical surface over an irregular cornea, which glasses cannot do. Cross-linking protects the cornea you have; lenses let you see with it. In China, fitting with a first lens runs about $250–600 per eye for corneal RGP and $600–1,200 for scleral lenses (researched July 2026), against published US figures of roughly $1,500–3,500 per eye for scleral fitting. The practical caution is that fitting is iterative and lenses need periodic remakes and replacement, so you need a fitter you can reach — arrange local support rather than assuming remakes can be handled from abroad.
Does eye rubbing really matter?
It is the most consistently reported modifiable risk factor, and 68.4% of patients in a Chinese hospital cohort had a rubbing history. If allergy or dryness is driving the itch, treating that is part of treating the cone. It costs nothing and it is worth more to the eye than the difference between two quotes.